Valuation Biogen Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-09-16 pm EDT			5-day change	1st Jan Change
199.58 ^USD	+2.02%		-0.61%	-22.87%

Sep. 12	Biogen Inc. Announces Elects Lloyd B. Minor and Sir Menelas Pangalos as Directors, Effective October 1, 2024 and January 1, 2025, Respectively	CI
Sep. 10	C4 Therapeutics Delivers Final Development Candidate Under Biogen Deal	MT

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	53,543	37,679	35,242	39,877	37,495	28,496	-	-
Change	-	-29.63%	-6.47%	13.15%	-5.97%	-24%	-	-
Enterprise Value (EV) ¹	51,733	41,723	37,820	40,560	43,384	31,705	29,237	25,692
Change	-	-19.35%	-9.35%	7.24%	6.96%	-26.92%	-7.78%	-12.13%
P/E ratio	9.44x	9.87x	23.1x	13.3x	32.5x	15.3x	13.9x	11.6x
PBR	3.87x	3.7x	3.26x	3.02x	2.53x	1.66x	1.46x	1.29x
PEG	-	-0.5x	-0.4x	0x	-0.5x	0.3x	1.3x	0.6x
Capitalization / Revenue	3.72x	2.8x	3.21x	3.92x	3.81x	2.96x	2.97x	2.91x
EV / Revenue	3.6x	3.1x	3.44x	3.99x	4.41x	3.3x	3.05x	2.62x
EV / EBITDA	6.41x	5.56x	9.13x	11.2x	14.3x	9.47x	8.43x	6.89x
EV / EBIT	7x	6.1x	10.3x	13.1x	17x	10.6x	9.51x	7.78x
EV / FCF	7.88x	11x	11.2x	35.5x	34.2x	15x	10.4x	9.2x
FCF Yield	12.7%	9.12%	8.94%	2.82%	2.93%	6.65%	9.61%	10.9%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	31.42	24.8	10.4	20.87	7.97	12.77	14.12	16.9
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	14,378	13,445	10,982	10,173	9,836	9,622	9,582	9,802
EBITDA ¹	8,070	7,504	4,144	3,618	3,040	3,347	3,467	3,728
EBIT ¹	7,390	6,837	3,656	3,099	2,545	2,987	3,073	3,301
Net income ¹	5,888	4,001	1,556	3,047	1,161	1,924	2,164	2,472
Net Debt ¹	-1,810	4,044	2,578	683	5,888	3,210	741.5	-2,804
Reference price ²	296.73	244.86	239.92	276.92	258.77	195.63	195.63	195.63
Nbr of stocks (in thousands)	180,442	153,882	146,893	144,001	144,898	145,662	-	-
Announcement Date	1/30/20	2/3/21	2/3/22	2/15/23	2/13/24	-	-	-

¹USD in Million²USD

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
BIOGEN INC.	15.32x	3.3x	9.47x	-.--%	28.5B
CSL LIMITED	31.21x	6.78x	19.8x	+1.48%	97.6B
SAMSUNG BIOLOGICS CO.,LTD.	65.97x	15.67x	36.14x	-.--%	53.06B
UCB	72.42x	5.64x	23.64x	+0.87%	34.28B
BIOMARIN PHARMACEUTICAL INC.	41.07x	5.53x	27.95x	-.--%	16.16B
ALTEOGEN INC.	2366.67x	225.11x	-3681.63x	-	12.78B
INCYTE CORPORATION	69.12x	2.32x	28.57x	-.--%	12.24B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	161.63x	29.11x	89.97x	+0.10%	12.12B
SWEDISH ORPHAN BIOVITRUM AB	34x	5.08x	14.11x	-.--%	10.97B
INNOVENT BIOLOGICS, INC.	-79.34x	7.53x	-87.44x	-.--%	9.21B
Average	277.81x	30.61x	-351.94x	+0.27%	28.69B
Weighted average by Cap.	149.26x	18.31x	-142.49x	+0.64%